| |
| Names | |
|---|---|
| Preferred IUPAC name
6-(2,5-Dichlorophenyl)1,3,5-triazine-2,4-diamine | |
| Other names
DCPDAT, Dicloguamine, MN-1695. | |
| Identifiers | |
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| Properties | |
| C9H7Cl2N5 | |
| Molar mass | 256.09 g·mol−1 |
| Pharmacology | |
| A02BX16 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Irsogladine is a phosphodiesterase inhibitor.[1]
Antiulcer drug.
2,4-Dichloro-6-(2,5-dichlorophenyl)-1,3,5-triazine [61479-79-6] (1) (2) Dicyandiamide [461-58-5] (3) 2,5-Dichlorobenzonitrile [21663-61-6] (4)
|
| |
|---|---|
| H2 antagonists ("-tidine") |
|
| Prostaglandins (E)/ analogues ("-prost-") |
|
| Proton-pump inhibitors ("-prazole") |
|
| Potassium-competitive acid blockers ("-prazan") |
|
| Others |
|
| Combinations |
|
| |
| |
 | This article about an organic compound is a stub. You can help Wikipedia by expanding it. |
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
